R-DXd showed a 50.5% objective response rate in platinum-resistant ovarian cancer, with a 5.6 mg/kg dose deemed optimal for further study. The safety profile was manageable, with 93.5% experiencing ...

Raludotatug deruxtecan is a specifically engineered, potential first-in-class CDH6 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed by ...

The Boardman SLR 9.8 tops the bargain brand's new range of road bikes. Can it compete with the best in the business for half ...

All toothpaste tubes sold nationwide will now be made of recyclable polyethylene as part of a sustainability drive led by toothpaste manufacturers. Toothpaste tubes have previously presented a ...